Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-16 5:16 pm Sale | 13D | AILERON THERAPEUTICS INC N ALRN | Satter Muneer A | 830,466 4.9% | -186,567 (-18.34%) | View |
| 2024-03-05 7:14 pm Purchase | 13G | AILERON THERAPEUTICS INC N ALRN | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 1,812,627 6.2% | 1,812,627 (New Position) | View |
| 2024-03-05 4:30 pm Purchase | 13D | AILERON THERAPEUTICS INC N ALRN | Satter Muneer A | 1,017,033 5.9% | 9,545 (+0.95%) | View |
| 2024-02-14 10:28 am Sale | 13G | AILERON THERAPEUTICS INC N ALRN | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -236,835 (Position Closed) | View |
| 2024-02-05 1:20 pm Unchanged | 13G | AILERON THERAPEUTICS INC N ALRN | Kapnick Scott | 0 0% | 0 (Unchanged) | View |
| 2023-11-13 5:08 pm Purchase | 13G | AILERON THERAPEUTICS INC N ALRN | BIOS Fund I LP | 542,256 9.99% | 542,256 (New Position) | View |
| 2023-11-03 4:30 pm Purchase | 13D | AILERON THERAPEUTICS INC N ALRN | Satter Muneer A | 1,007,488 19.9% | 1,007,488 (New Position) | View |
| 2023-02-14 11:42 am Purchase | 13G | AILERON THERAPEUTICS INC N ALRN | BIOTECHNOLOGY VALUE FUND L P | 236,835 5.2% | 236,835 (New Position) | View |
| 2023-02-14 07:54 am Sale | 13G | AILERON THERAPEUTICS INC ALRN | Kapnick Scott | 379,608 8.4% | -7,212,614 (-95.00%) | View |
| 2022-02-14 09:02 am Purchase | 13G | AILERON THERAPEUTICS INC ALRN | Kapnick Scott | 7,592,222 8.4% | 4,215,000 (+124.81%) | View |
| 2021-02-10 09:53 am Unchanged | 13G | AILERON THERAPEUTICS INC ALRN | JENNISON ASSOCIATES LLC | 1,542,288 3.7% | 0 (Unchanged) | View |
| 2021-02-09 12:39 pm Unchanged | 13G | AILERON THERAPEUTICS INC ALRN | PRUDENTIAL FINANCIAL INC PRU | 1,542,288 3.65% | 0 (Unchanged) | View |
| 2021-01-19 5:21 pm Purchase | 13G | AILERON THERAPEUTICS INC ALRN | BIOTECHNOLOGY VALUE FUND L P | 5,265,555 6.3% | 5,265,555 (New Position) | View |
| 2021-01-08 4:04 pm Purchase | 13D | AILERON THERAPEUTICS INC ALRN | Satter Muneer A | 20,340,792 19.9% | 9,000,000 (+79.36%) | View |
| 2020-06-09 5:13 pm Purchase | 13D | AILERON THERAPEUTICS INC ALRN | Satter Muneer A | 11,340,792 19.9% | 3,700,000 (+48.42%) | View |
| 2020-06-08 5:16 pm Purchase | 13G | AILERON THERAPEUTICS INC ALRN | Kapnick Scott | 3,377,222 8.8% | 3,377,222 (New Position) | View |
| 2020-04-16 07:28 am Sale | 13D | AILERON THERAPEUTICS INC ALRN | Novartis Bioventures Ltd | 1,199,904 4.31% | -372,381 (-23.68%) | View |
| 2020-04-13 4:01 pm Sale | 13D | AILERON THERAPEUTICS INC ALRN | Novartis Bioventures Ltd | 1,572,285 5.65% | -309,834 (-16.46%) | View |
| 2020-03-18 07:01 am Sale | 13D | AILERON THERAPEUTICS INC ALRN | Novartis Bioventures Ltd | 1,882,119 6.77% | -197,275 (-9.49%) | View |
| 2020-02-14 4:38 pm Sale | 13D | AILERON THERAPEUTICS INC ALRN | GSK plc GSK | 504,926 1.8% | -926,593 (-64.73%) | View |